Symbols / GSK Stock $50.99 +0.18% GSK plc

Healthcare • Drug Manufacturers - General • United Kingdom • NYQ
GSK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Luke Victor Miels
Exch · Country NYQ · United Kingdom
Market Cap 102.36B
Enterprise Value 220.22B
Income 5.83B
Sales 32.78B
FCF (ttm) 3.02B
Book/sh 11.08
Cash/sh 0.86
Employees 66,841
Insider 10d —
IPO Mar 28, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 46.54%
P/E 13.18
Forward P/E 9.74
PEG 0.50
P/S 3.12
P/B 4.60
P/C —
EV/EBITDA 19.26
EV/Sales 6.72
Quick Ratio 0.51
Current Ratio 0.79
Debt/Eq 109.70
LT Debt/Eq —
EPS (ttm) 3.87
EPS next Y 5.23
EPS Growth 8.40%
Revenue Growth 1.50%
EPS Gr Q/Q 7.00%
Rev Gr Q/Q —
Earnings (next) 2026-07-29
Earnings (prior) 2026-04-29
ROA 10.02%
ROE 40.91%
ROIC —
Gross Margin 72.87%
Oper. Margin 36.28%
Profit Margin 17.78%
Shs Outstand 2.01B
Shs Float 3.89B
Insider Own 0.06%
Instit Own 19.65%
Short Float 0.66%
Short Ratio 3.05
Short Interest 13.23M
52W High 61.70
vs 52W High -17.36%
52W Low 35.45
vs 52W Low 43.84%
Beta 0.30
Impl. Vol. 0.10%
Rel Volume 0.85
Avg Volume 4.60M
Volume 3.93M
Target (mean) $57.65
Tgt Median $56.00
Tgt Low $47.00
Tgt High $70.00
# Analysts 8
Recom Hold
Prev Close $50.90
Price $50.99
Change 0.18%
About

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$57.65
Mean price target
2. Current target
$50.99
Latest analyst target
3. DCF / Fair value
$27.07
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$50.99
Low
$47.00
High
$70.00
Mean
$57.65

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-06 down Barclays Equal-Weight → Underweight —
2024-11-12 down Jefferies Buy → Hold —
2024-10-31 down Guggenheim Buy → Neutral —
2024-07-08 down UBS Buy → Neutral —
2024-07-02 main Jefferies Buy → Buy $53
2024-05-30 init Goldman Sachs — → Neutral $47
2024-03-04 up Guggenheim Neutral → Buy —
2024-01-23 init Morgan Stanley — → Equal-Weight $44
2024-01-03 up Jefferies Hold → Buy $48
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-27 Conrad (D) — — 13 $54.59 $709
2026-04-22 Martinez-Davis (Maya) — — 6 $55.70 $334
2026-04-14 Martinez-Davis (Maya) — — 293 $59.17 $17,336
2026-04-14 Martinez-Davis (Maya) — — 152 $58.36 $8,870
2026-04-14 Ramakrishnan (Shobie) — — 601 $59.17 $35,561
2026-04-13 Conrad (D) — — 11 $58.34 $641
2026-04-13 Conrad (D) — — 65 $58.35 $3,792
2026-04-09 Barron (Hal V) — — 26 $58.93 $1,532
2026-04-09 Beal (Anne M.D.) — — 32 $58.93 $1,885
2026-04-09 Dietz (Hal) — — 30 $58.93 $1,767
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
32,667.00
+4.11%
31,376.00
+3.46%
30,328.00
+3.42%
29,324.00
Operating Revenue
32,667.00
+4.11%
31,376.00
+3.46%
30,328.00
+3.42%
29,324.00
Cost Of Revenue
9,017.00
-0.34%
9,048.00
+5.64%
8,565.00
-10.35%
9,554.00
Reconciled Cost Of Revenue
9,017.00
-0.34%
9,048.00
+5.64%
8,565.00
-10.35%
9,554.00
Gross Profit
23,650.00
+5.92%
22,328.00
+2.60%
21,763.00
+10.08%
19,770.00
Operating Expense
15,312.00
-8.78%
16,786.00
+16.42%
14,418.00
+10.56%
13,041.00
Research And Development
7,525.00
+17.56%
6,401.00
+2.86%
6,223.00
+13.39%
5,488.00
Selling General And Administration
9,088.00
-17.49%
11,015.00
+17.37%
9,385.00
+12.10%
8,372.00
General And Administrative Expense
9,088.00
-17.49%
11,015.00
+17.37%
9,385.00
+12.10%
8,372.00
Other Operating Expenses
—
9.00
—
—
Total Expenses
24,329.00
-5.83%
25,834.00
+12.40%
22,983.00
+1.72%
22,595.00
Operating Income
8,338.00
+50.45%
5,542.00
-24.55%
7,345.00
+9.15%
6,729.00
Total Operating Income As Reported
7,932.00
+97.26%
4,021.00
-40.39%
6,745.00
+4.85%
6,433.00
EBITDA
10,402.00
+56.00%
6,668.00
-26.59%
9,083.00
+5.60%
8,601.00
Normalized EBITDA
10,707.00
+31.75%
8,127.00
-15.55%
9,624.00
+8.45%
8,874.00
Reconciled Depreciation
2,314.00
-9.29%
2,551.00
+11.20%
2,294.00
+6.85%
2,147.00
EBIT
8,088.00
+96.45%
4,117.00
-39.36%
6,789.00
+5.19%
6,454.00
Total Unusual Items
-305.00
+79.10%
-1,459.00
-169.69%
-541.00
-98.17%
-273.00
Total Unusual Items Excluding Goodwill
-305.00
+79.10%
-1,459.00
-169.69%
-541.00
-98.17%
-273.00
Special Income Charges
-813.00
+34.06%
-1,233.00
-75.14%
-704.00
+42.81%
-1,231.00
Other Special Charges
232.00
+144.79%
-518.00
-495.40%
-87.00
+76.86%
-376.00
Restructuring And Mergern Acquisition
581.00
-66.82%
1,751.00
+121.37%
791.00
-50.78%
1,607.00
Net Income
5,716.00
+121.98%
2,575.00
-47.75%
4,928.00
-67.05%
14,956.00
Pretax Income
7,401.00
+112.86%
3,477.00
-42.66%
6,064.00
+7.75%
5,628.00
Net Non Operating Interest Income Expense
-633.00
-4.98%
-603.00
+17.96%
-735.00
+11.02%
-826.00
Interest Expense Non Operating
687.00
+7.34%
640.00
-11.72%
725.00
-12.23%
826.00
Net Interest Income
-633.00
-4.98%
-603.00
+17.96%
-735.00
+11.02%
-826.00
Interest Expense
687.00
+7.34%
640.00
-11.72%
725.00
-12.23%
826.00
Interest Income Non Operating
56.00
-6.67%
60.00
+25.00%
48.00
+54.84%
31.00
Interest Income
56.00
-6.67%
60.00
+25.00%
48.00
+54.84%
31.00
Tax Provision
1,112.00
+111.41%
526.00
-30.42%
756.00
+6.93%
707.00
Tax Rate For Calcs
0.00
-0.68%
0.00
+21.02%
0.00
-0.79%
0.00
Tax Effect Of Unusual Items
-45.83
+79.24%
-220.72
-226.38%
-67.62
-96.60%
-34.40
Net Income Including Noncontrolling Interests
6,289.00
+113.11%
2,951.00
-44.40%
5,308.00
-66.02%
15,621.00
Net Income From Continuing Operation Net Minority Interest
5,716.00
+121.98%
2,575.00
-47.75%
4,928.00
+15.79%
4,256.00
Net Income From Continuing And Discontinued Operation
5,716.00
+121.98%
2,575.00
-47.75%
4,928.00
-67.05%
14,956.00
Net Income Continuous Operations
6,289.00
+113.11%
2,951.00
-44.40%
5,308.00
+7.86%
4,921.00
Net Income Discontinuous Operations
—
0.00
0.00
-100.00%
10,700.00
Minority Interests
-573.00
-52.39%
-376.00
+1.05%
-380.00
+42.86%
-665.00
Normalized Income
5,975.17
+56.69%
3,813.28
-29.40%
5,401.38
+20.17%
4,494.60
Net Income Common Stockholders
5,716.00
+121.98%
2,575.00
-47.75%
4,928.00
-67.05%
14,956.00
Otherunder Preferred Stock Dividend
0.00
0.00
0.00
0.00
Diluted EPS
2.78
+123.15%
1.24
-48.12%
2.40
-67.26%
7.32
Basic EPS
2.82
+123.26%
1.26
-48.03%
2.43
-67.26%
7.43
Basic Average Shares
2,025.50
-0.64%
2,038.50
+0.62%
2,026.00
+0.65%
2,013.00
Diluted Average Shares
2,058.50
-0.60%
2,071.00
+0.75%
2,055.50
+0.66%
2,042.00
Diluted NI Availto Com Stockholders
5,716.00
+121.98%
2,575.00
-47.75%
4,928.00
-67.05%
14,956.00
Rent Expense Supplemental
—
30.00
+11.11%
27.00
+58.82%
17.00
Total Other Finance Cost
2.00
-91.30%
23.00
-60.34%
58.00
+87.10%
31.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
61,118.00
+2.78%
59,463.00
+0.78%
59,005.00
-1.90%
60,146.00
Current Assets
17,510.00
+3.02%
16,997.00
-8.83%
18,644.00
-10.23%
20,769.00
Cash Cash Equivalents And Short Term Investments
3,159.00
-14.94%
3,714.00
-25.60%
4,992.00
-34.97%
7,677.00
Cash And Cash Equivalents
3,150.00
-14.70%
3,693.00
+34.49%
2,746.00
-22.06%
3,523.00
Other Short Term Investments
9.00
-57.14%
21.00
-99.07%
2,246.00
-45.93%
4,154.00
Accounts Receivable
5,913.00
+6.29%
5,563.00
-5.79%
5,905.00
+8.31%
5,452.00
Gross Accounts Receivable
5,913.00
+6.29%
5,563.00
-7.13%
5,990.00
+8.06%
5,543.00
Allowance For Doubtful Accounts Receivable
—
-99.00
-16.47%
-85.00
+6.59%
-91.00
Other Receivables
662.00
+51.83%
436.00
-22.14%
560.00
-26.89%
766.00
Taxes Receivable
799.00
-14.64%
936.00
-0.21%
938.00
+4.57%
897.00
Inventory
5,924.00
+4.50%
5,669.00
+3.11%
5,498.00
+6.84%
5,146.00
Raw Materials
608.00
-55.33%
1,361.00
-14.62%
1,594.00
+1.14%
1,576.00
Work In Process
3,699.00
+37.87%
2,683.00
+9.55%
2,449.00
+7.13%
2,286.00
Finished Goods
1,617.00
-0.49%
1,625.00
+11.68%
1,455.00
+13.32%
1,284.00
Prepaid Assets
385.00
-1.28%
390.00
+9.86%
355.00
+3.50%
343.00
Restricted Cash
247.00
+39.55%
177.00
-6.84%
190.00
-5.00%
200.00
Assets Held For Sale Current
300.00
+9900.00%
3.00
-96.05%
76.00
-22.45%
98.00
Hedging Assets Current
121.00
+11.01%
109.00
-16.15%
130.00
-31.58%
190.00
Total Non Current Assets
43,608.00
+2.69%
42,466.00
+5.22%
40,361.00
+2.50%
39,377.00
Net PPE
10,048.00
-0.25%
10,073.00
+1.17%
9,957.00
+3.50%
9,620.00
Gross PPE
20,940.00
+1.87%
20,556.00
+1.68%
20,216.00
+0.39%
20,138.00
Accumulated Depreciation
-10,892.00
-3.90%
-10,483.00
-2.18%
-10,259.00
+2.46%
-10,518.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
6,157.00
-3.42%
6,375.00
-1.24%
6,455.00
-2.90%
6,648.00
Buildings And Improvements
531.00
-16.51%
636.00
-15.31%
751.00
+33.87%
561.00
Machinery Furniture Equipment
11,735.00
+4.62%
11,217.00
+3.04%
10,886.00
-1.69%
11,073.00
Construction In Progress
2,511.00
+8.23%
2,320.00
+9.43%
2,120.00
+14.59%
1,850.00
Other Properties
6.00
-25.00%
8.00
+100.00%
4.00
-33.33%
6.00
Goodwill And Other Intangible Assets
23,766.00
+5.64%
22,497.00
+4.25%
21,579.00
+1.01%
21,364.00
Goodwill
7,018.00
+0.52%
6,982.00
+2.51%
6,811.00
-3.34%
7,046.00
Other Intangible Assets
16,748.00
+7.95%
15,515.00
+5.06%
14,768.00
+3.14%
14,318.00
Long Term Equity Investment
89.00
-7.29%
96.00
+74.55%
55.00
-25.68%
74.00
Non Current Deferred Taxes Assets
6,520.00
-3.51%
6,757.00
+11.70%
6,049.00
+6.91%
5,658.00
Total Liabilities Net Minority Interest
45,162.00
-2.62%
46,377.00
+0.36%
46,210.00
-7.67%
50,050.00
Current Liabilities
21,391.00
-1.41%
21,697.00
+2.99%
21,068.00
-7.64%
22,810.00
Payables
4,471.00
-2.49%
4,585.00
+0.48%
4,563.00
-4.04%
4,755.00
Accounts Payable
3,535.00
+2.11%
3,462.00
-6.86%
3,717.00
-3.85%
3,866.00
Other Payable
438.00
+4.29%
420.00
+21.39%
346.00
-17.22%
418.00
Pensionand Other Post Retirement Benefit Plans Current
138.00
+10.40%
125.00
-0.79%
126.00
+0.00%
126.00
Total Tax Payable
498.00
-29.16%
703.00
+40.60%
500.00
+6.16%
471.00
Current Debt And Capital Lease Obligation
3,012.00
+28.22%
2,349.00
-16.49%
2,813.00
-28.82%
3,952.00
Current Debt
2,875.00
+31.82%
2,181.00
-17.91%
2,657.00
-29.80%
3,785.00
Current Capital Lease Obligation
137.00
-18.45%
168.00
+7.69%
156.00
-6.59%
167.00
Other Current Liabilities
1,348.00
+15.02%
1,172.00
+11.30%
1,053.00
-18.31%
1,289.00
Total Non Current Liabilities Net Minority Interest
23,771.00
-3.68%
24,680.00
-1.84%
25,142.00
-7.70%
27,240.00
Long Term Debt And Capital Lease Obligation
14,708.00
+0.49%
14,637.00
-3.74%
15,205.00
-10.74%
17,035.00
Long Term Debt
14,015.00
+2.28%
13,703.00
-3.19%
14,154.00
-12.60%
16,194.00
Long Term Capital Lease Obligation
693.00
-25.80%
934.00
-11.13%
1,051.00
+24.97%
841.00
Long Term Provisions
610.00
+3.57%
589.00
+18.99%
495.00
-6.95%
532.00
Defined Pension Benefit
1,115.00
+24.16%
898.00
+41.64%
634.00
+176.86%
229.00
Non Current Pension And Other Postretirement Benefit Plans
1,687.00
-9.50%
1,864.00
-20.34%
2,340.00
-9.27%
2,579.00
Tradeand Other Payables Non Current
896.00
-3.55%
929.00
+0.54%
924.00
-0.86%
932.00
Non Current Deferred Revenue
121.00
-26.67%
165.00
-35.04%
254.00
+206.02%
83.00
Non Current Deferred Taxes Liabilities
291.00
-23.82%
382.00
+22.83%
311.00
+7.61%
289.00
Other Non Current Liabilities
5,385.00
-11.84%
6,108.00
+8.90%
5,609.00
-2.94%
5,779.00
Stockholders Equity
16,377.00
+19.79%
13,671.00
+2.43%
13,347.00
+25.94%
10,598.00
Common Stock Equity
16,377.00
+19.79%
13,671.00
+2.43%
13,347.00
+25.94%
10,598.00
Capital Stock
1,349.00
+0.07%
1,348.00
+0.00%
1,348.00
+0.07%
1,347.00
Common Stock
1,349.00
+0.07%
1,348.00
+0.00%
1,348.00
+0.07%
1,347.00
Share Issued
4,315.45
+0.03%
4,314.30
+0.05%
4,312.15
+0.02%
4,311.34
Ordinary Shares Number
4,012.55
-1.67%
4,080.82
+0.61%
4,056.26
-0.93%
4,094.22
Treasury Shares Number
302.89
+29.73%
233.49
-8.75%
255.89
+17.85%
217.12
Additional Paid In Capital
3,498.00
+0.72%
3,473.00
+0.64%
3,451.00
+0.32%
3,440.00
Retained Earnings
10,209.00
+30.95%
7,796.00
+7.69%
7,239.00
+65.92%
4,363.00
Minority Interest
-421.00
+28.03%
-585.00
-5.98%
-552.00
-9.96%
-502.00
Total Equity Gross Minority Interest
15,956.00
+21.93%
13,086.00
+2.27%
12,795.00
+26.73%
10,096.00
Total Capitalization
30,392.00
+11.03%
27,374.00
-0.46%
27,501.00
+2.65%
26,792.00
Working Capital
-3,881.00
+17.43%
-4,700.00
-93.89%
-2,424.00
-18.77%
-2,041.00
Invested Capital
33,267.00
+12.56%
29,555.00
-2.00%
30,158.00
-1.37%
30,577.00
Total Debt
17,720.00
+4.32%
16,986.00
-5.73%
18,018.00
-14.15%
20,987.00
Net Debt
13,740.00
+12.71%
12,191.00
-13.32%
14,065.00
-14.53%
16,456.00
Capital Lease Obligations
830.00
-24.68%
1,102.00
-8.70%
1,207.00
+19.74%
1,008.00
Net Tangible Assets
-7,389.00
+16.28%
-8,826.00
-7.22%
-8,232.00
+23.54%
-10,766.00
Tangible Book Value
-7,389.00
+16.28%
-8,826.00
-7.22%
-8,232.00
+23.54%
-10,766.00
Available For Sale Securities
790.00
-6.84%
848.00
-9.79%
940.00
-19.93%
1,174.00
Current Provisions
938.00
-51.80%
1,946.00
+161.56%
744.00
+14.11%
652.00
Derivative Product Liabilities
67.00
0.00
—
0.00
Financial Assets
0.00
-100.00%
1.00
0.00
0.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
263.00
-8.68%
288.00
+28.57%
224.00
-31.50%
327.00
Investmentin Financial Assets
1,053.00
-7.31%
1,136.00
-2.41%
1,164.00
-22.45%
1,501.00
Investmentsin Associatesat Cost
89.00
-7.29%
96.00
+74.55%
55.00
-14.06%
64.00
Investmentsin Joint Venturesat Cost
0.00
0.00
0.00
-100.00%
10.00
Non Current Accrued Expenses
6.00
+0.00%
6.00
+50.00%
4.00
-63.64%
11.00
Other Equity Interest
-282.00
+28.97%
-397.00
-37.85%
-288.00
+18.41%
-353.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
7,741.00
+18.11%
6,554.00
-3.16%
6,768.00
-8.58%
7,403.00
Net Income From Continuing Operations
6,289.00
+113.11%
2,951.00
-44.40%
5,308.00
+7.86%
4,921.00
Depreciation
1,056.00
-3.74%
1,097.00
+1.39%
1,082.00
+1.98%
1,061.00
Amortization Cash Flow
1,258.00
-13.48%
1,454.00
+19.97%
1,212.00
+11.60%
1,086.00
Depreciation And Amortization
2,314.00
-9.29%
2,551.00
+11.20%
2,294.00
+6.85%
2,147.00
Other Non Cash Items
568.00
+42.71%
398.00
-15.32%
470.00
+34.29%
350.00
Stock Based Compensation
374.00
+8.72%
344.00
+12.05%
307.00
-11.27%
346.00
Deferred Tax
1,112.00
+111.41%
526.00
-30.42%
756.00
+6.93%
707.00
Gain Loss On Investment Securities
-4.00
+60.00%
-10.00
—
-1.00
Gain Loss On Sale Of PPE
-49.00
+71.18%
-170.00
-1316.67%
-12.00
+93.51%
-185.00
Change In Working Capital
-1,437.00
-168.76%
2,090.00
+674.18%
-364.00
-234.81%
270.00
Change In Receivables
-1,097.00
-422.65%
340.00
+152.39%
-649.00
-5.36%
-616.00
Change In Inventory
-140.00
+52.38%
-294.00
+30.66%
-424.00
-57.62%
-269.00
Change In Payable
474.00
+160.08%
-789.00
-217.06%
674.00
+37.83%
489.00
Change In Other Current Assets
-1,139.00
-214.01%
999.00
+318.60%
-457.00
+52.49%
-962.00
Change In Other Current Liabilities
465.00
-74.65%
1,834.00
+272.76%
492.00
-69.78%
1,628.00
Investing Cash Flow
-4,233.00
-244.43%
-1,229.00
+22.95%
-1,595.00
+81.82%
-8,772.00
Net PPE Purchase And Sale
-1,324.00
+0.75%
-1,334.00
-3.73%
-1,286.00
-28.99%
-997.00
Purchase Of PPE
-1,348.00
+3.65%
-1,399.00
-6.47%
-1,314.00
-14.96%
-1,143.00
Sale Of PPE
24.00
-63.08%
65.00
+132.14%
28.00
-80.82%
146.00
Capital Expenditure
-2,985.00
-0.10%
-2,982.00
-27.22%
-2,344.00
-3.81%
-2,258.00
Net Investment Purchase And Sale
11.00
-47.62%
21.00
-70.83%
72.00
+7100.00%
1.00
Sale Of Investment
—
21.00
-70.83%
72.00
+7100.00%
1.00
Net Business Purchase And Sale
-1,639.00
-219.81%
1,368.00
+370.10%
291.00
+109.28%
-3,136.00
Purchase Of Business
-1,828.00
-85.02%
-988.00
+37.90%
-1,591.00
+52.85%
-3,374.00
Gain Loss On Sale Of Business
9.00
+80.00%
5.00
+600.00%
-1.00
+97.22%
-36.00
Net Intangibles Purchase And Sale
-1,522.00
-4.82%
-1,452.00
-42.63%
-1,018.00
-10.77%
-919.00
Purchase Of Intangibles
-1,637.00
-3.41%
-1,583.00
-53.69%
-1,030.00
+7.62%
-1,115.00
Net Other Investing Changes
—
-1.00
—
-3,791.00
Financing Cash Flow
-3,685.00
+22.03%
-4,726.00
+16.22%
-5,641.00
-785.42%
823.00
Net Issuance Payments Of Debt
1,506.00
+229.16%
-1,166.00
+50.80%
-2,370.00
+48.72%
-4,622.00
Issuance Of Debt
3,194.00
+138.18%
1,341.00
+501.35%
223.00
-89.10%
2,046.00
Repayment Of Debt
-1,688.00
+32.67%
-2,507.00
+3.32%
-2,593.00
+61.11%
-6,668.00
Long Term Debt Issuance
1,979.00
+84.09%
1,075.00
+382.06%
223.00
-78.24%
1,025.00
Long Term Debt Payments
-1,400.00
+13.31%
-1,615.00
+28.54%
-2,260.00
+66.11%
-6,668.00
Net Long Term Debt Issuance
579.00
+207.22%
-540.00
+73.49%
-2,037.00
+63.90%
-5,643.00
Short Term Debt Issuance
1,215.00
+356.77%
266.00
0.00
-100.00%
1,021.00
Short Term Debt Payments
-288.00
+67.71%
-892.00
-167.87%
-333.00
0.00
Net Short Term Debt Issuance
927.00
+248.08%
-626.00
-87.99%
-333.00
-132.62%
1,021.00
Net Common Stock Issuance
-1,362.00
-6910.00%
20.00
+100.00%
10.00
-60.00%
25.00
Common Stock Payments
-1,377.00
0.00
0.00
—
Common Stock Dividend Paid
-2,564.00
-4.91%
-2,444.00
-8.77%
-2,247.00
+35.19%
-3,467.00
Cash Dividends Paid
-2,564.00
-4.91%
-2,444.00
-8.77%
-2,247.00
+35.19%
-3,467.00
Repurchase Of Capital Stock
-1,377.00
0.00
0.00
—
Net Other Financing Charges
46.00
-66.67%
138.00
-59.53%
341.00
-96.74%
10,458.00
Changes In Cash
-177.00
-129.55%
599.00
+227.99%
-468.00
+14.29%
-546.00
Effect Of Exchange Rate Changes
-19.00
+64.81%
-54.00
+45.45%
-99.00
-165.13%
152.00
Beginning Cash Position
3,403.00
+19.07%
2,858.00
-16.55%
3,425.00
-10.32%
3,819.00
End Cash Position
3,207.00
-5.76%
3,403.00
+19.07%
2,858.00
-16.55%
3,425.00
Free Cash Flow
4,756.00
+33.15%
3,572.00
-19.26%
4,424.00
-14.01%
5,145.00
Common Stock Issuance
15.00
-25.00%
20.00
+100.00%
10.00
-60.00%
25.00
Dividends Received CFI
87.00
+180.65%
31.00
-86.58%
231.00
+3750.00%
6.00
Interest Paid CFF
-679.00
-7.44%
-632.00
+17.49%
-766.00
+9.67%
-848.00
Interest Received CFI
154.00
+11.59%
138.00
+20.00%
115.00
+79.69%
64.00
Issuance Of Capital Stock
15.00
-25.00%
20.00
+100.00%
10.00
-60.00%
25.00
Sale Of Business
189.00
-91.98%
2,356.00
+25.19%
1,882.00
+690.76%
238.00
Sale Of Intangibles
115.00
-12.21%
131.00
+991.67%
12.00
-93.88%
196.00
Taxes Refund Paid
-1,202.00
+8.03%
-1,307.00
+1.58%
-1,328.00
-1.37%
-1,310.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category